- The GLP-1 drug shortage is over. What’s next for the compounders? Yahoo Finance
- Patients Cut Off From Cheaper Obesity Drugs as the F.D.A. Halts Sales of Copycats The New York Times
- The Era of Compounded GLP-1 Drugs Is Over. What Now? Medscape
- A shadowy market for weight-loss drugs has emerged online Science Current-News-Report
- The Ozempic shortage is over. What now? George Mason University
